Absence of citrulline‐specific autoantibodies in animal models of autoimmunity
Open Access
- 6 July 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (7) , 2370-2372
- https://doi.org/10.1002/art.20296
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritisClinical and Applied Immunology Reviews, 2004
- Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophagesAnnals of the Rheumatic Diseases, 2004
- PAD, a growing family of citrullinating enzymes: genes, features and involvement in diseaseBioEssays, 2003
- Citrullination of synovial proteins in murine models of rheumatoid arthritisArthritis & Rheumatism, 2003
- Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in miceArthritis & Rheumatism, 2003
- The Danger Model: A Renewed Sense of SelfScience, 2002
- The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the α- and β-Chains of FibrinThe Journal of Immunology, 2001
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.Journal of Clinical Investigation, 1998
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative DiseaseAnnual Review of Immunology, 1991